BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:     

The Market for Restriction Enzymes Cutting Out Your Competition

The Market for Restriction Enzymes Cutting Out Your Competition


It is difficult to imagine life in the lab today without the benefit of restriction enzymes. Because they are so ubiquitous, these tools have become indispensable to many scientists even at the same time that they are often taken for granted. Nonetheless, restriction enzymes support many quintessential molecular biology applications including cloning, genotyping, mutation analysis and sequencing.

Scientists must decide amongst the many suppliers that offer a variety of restriction enzymes—often with similar label specifications. While some industry observers have suggested that many researchers make their decisions based solely upon price or brand image, a comprehensive evaluation of all of the key market drivers has not been conducted until now.

Produced from the results of a 23-question survey of researchers who use restriction enzymes, The Market for Restriction Enzymes: Cutting Out Your Competition examines what motivates scientists to purchase a restriction enzyme from one supplier over another and whether market segment and geographic location influence these decisions. It will provide insights into scientists’ purchasing preferences, i.e., how scientists prefer to buy restriction enzymes (e.g., central stockroom versus director from the supplier) and what factors (e.g., pricing, institutional practices, convenience) influence their purchasing decisions. This report will also help suppliers better understand the role of customer satisfaction and brand loyalty in these decisions.

Additionally, the report will present a detailed brand share analysis based upon usage rates and relative expenditure in two different market segments: industrial and academia and three geographic regions: North America, Europe and the rest of the world. Accompanying this analysis is an assessment of study respondents’ likelihood for brand switching and the motivations driving these decisions. Unique to this study is the estimation of brand equity in the restriction enzyme market based upon the past performance and future value of the major brands.

Publication Date: February 2006

Page Count: 142

Print Copy: $4,000

Company-wide Electronic Copy (includes print copy): $6,000



Price



Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.

Back to top